Clinical Trials Logo

Healthy Subject clinical trials

View clinical trials related to Healthy Subject.

Filter by:

NCT ID: NCT05318820 Completed - Healthy Subject Clinical Trials

A Clinical Study to Evaluate the Pharmacokinetics and Bioequivalence of HMPL-523 Tablets Produced by Two Different Manufacturers

Start date: June 1, 2022
Phase: Early Phase 1
Study type: Interventional

This is a monocentric, randomized, open-label, single-dose, three-cycle, partial replicate clinical study designed to evaluate the pharmacokinetic profile and bioequivalence of HMPL-523 Tablets produced by two different manufacturers in healthy subjects.

NCT ID: NCT05274802 Completed - Healthy Subject Clinical Trials

A Study of ALS-4 in Healthy Adults Subjects

Start date: March 20, 2021
Phase: Phase 1
Study type: Interventional

A Phase I trial to evaluate the safety, tolerability and Pharmacokinetics of ALS-4 (IM032) in a single ascending dose (SAD) and multiple ascending dose (MAD) in healthy adult subjects.

NCT ID: NCT05117385 Recruiting - Healthy Subject Clinical Trials

The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)

B-4-Immune
Start date: November 22, 2021
Phase: N/A
Study type: Interventional

This study will evaluate the capacity of botanical extracts to modulate immune mechanisms compared to a placebo group in healthy volunteers.

NCT ID: NCT05011799 Active, not recruiting - Prostate Carcinoma Clinical Trials

The Peer Genetic Study

Start date: January 8, 2020
Phase: N/A
Study type: Interventional

This trial studies how well a peer-based health education program works in reducing barriers and changing attitudes and beliefs of prostate cancer genetic screening in African American participants with or without a previous personal or family history of prostate cancer. Participating in a peer-based health educational program may help participants learn more about prostate cancer and how their personal or family history of disease may increase their risk of prostate cancer.

NCT ID: NCT04941313 Completed - Healthy Subject Clinical Trials

Phase 1 Study of 3D229 in Healthy Subjects

Start date: July 27, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1 Study to Evaluate the Safety and tolerability of 3D-229 in health subjects

NCT ID: NCT04803682 Completed - Healthy Subject Clinical Trials

A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths

Start date: January 8, 2016
Phase: Early Phase 1
Study type: Interventional

This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn if training eleventh grade high school students to be tobacco-free role models and mentors for ninth grade high school students is possible and will positively influence the younger peers.

NCT ID: NCT04614155 Active, not recruiting - Healthy Subject Clinical Trials

Project Self in Improving Cervical Cancer Screening Rates in Hispanic and African American Women

Start date: August 27, 2019
Phase: N/A
Study type: Interventional

This trial studies if Project Self can improve the rate of cervical cancer screening in Hispanic and African American women living in Houston, Texas. Project Self may help to improve cervical cancer screening rates by providing human papillomavirus (HPV) self-collection kits, education, counseling, and navigation.

NCT ID: NCT04358315 Recruiting - Healthy Subject Clinical Trials

Consumer Assessment of Tobacco Flavor and Odor

Start date: April 3, 2023
Phase:
Study type: Observational

This trial studies consumer assessments of tobacco flavor and odor. This study will compare the ability of expert and consumer panels to identify and characterize flavors, determine threshold detection levels for individual and mixed flavors, and identify the dominant flavor of mixtures.

NCT ID: NCT04312568 Completed - Healthy Subject Clinical Trials

Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil (XZP-5849)in Chinese Healthy Adult Male Subjects

Start date: August 10, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety , tolerability, and pharmacokinetics of ascending single dose Fadanafil (XZP-5849)in Chinese healthy adult male subjects. This is the first XZP-5849 clinical study

NCT ID: NCT04295096 Recruiting - Healthy Subject Clinical Trials

Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Title: Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy Subjects for the Development of Cellular Immunotherapy Product Background: CAR-T therapies are being developed that utilize modified immune cells to fight tumors. 'Off-the-shelf' allogeneic CAR-T technology has better efficacy and more promising clinical applications. Investigators want to use the cells of healthy subjects to perform the studies. To accomplish this, they are collecting PBMCs through apheresis. Objectives: To collect PBMCs from healthy subjects for product development for cell Immunotherapies.